Publikationen in Zusammenarbeit mit Forschern von Universidad de Castilla-La Mancha (20)

2024

  1. Morphological MRI features as prognostic indicators in brain metastases

    Cancer Imaging, Vol. 24, Núm. 1

  2. Volumetric analysis: Rethinking brain metastases response assessment

    Neuro-Oncology Advances, Vol. 6, Núm. 1

2023

  1. A comprehensive dataset of annotated brain metastasis MR images with clinical and radiomic data

    Scientific data, Vol. 10, Núm. 1, pp. 208

  2. CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation

    Cellular Oncology, Vol. 46, Núm. 1, pp. 65-77

  3. Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation (Cellular Oncology, (2023), 46, 1, (65-77), 10.1007/s13402-022-00734-0)

    Cellular Oncology

  4. Growth exponents reflect evolutionary processes and treatment response in brain metastases

    npj Systems Biology and Applications, Vol. 9, Núm. 1

2021

  1. Brain metastasis response to stereotactic radio surgery: A mathematical approach

    Mathematics, Vol. 9, Núm. 7

  2. Optimal combinations of chemotherapy and radiotherapy in low-grade gliomas: A mathematical approach

    Journal of Personalized Medicine, Vol. 11, Núm. 10

2019

  1. Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma (European Radiology, (2019), 29, 4, (1968-1977), 10.1007/s00330-018-5758-7)

    European Radiology

  2. Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcome

    Journal of the Royal Society, Interface, Vol. 16, Núm. 157, pp. 20190195

  3. Morphological MRI-based features provide pretreatment survival prediction in glioblastoma

    European Radiology, Vol. 29, Núm. 4, pp. 1968-1977

2018

  1. Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide

    Radiotherapy and Oncology, Vol. 128, Núm. 2, pp. 236-244

2017

  1. Glioblastoma: Pre-treatment geometry and texture of postcontrast T1 MRI matter

    2016 Conference on Design of Circuits and Integrated Systems, DCIS 2016 - Proceedings

  2. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study

    European Radiology, Vol. 27, Núm. 3, pp. 1096-1104

2016

  1. Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: A potential marker of survival

    British Journal of Radiology, Vol. 89, Núm. 1064

2015

  1. Combined therapies of antithrombotics and antioxidants delay in silico brain tumour progression

    Mathematical Medicine and Biology, Vol. 32, Núm. 3, pp. 239-262

  2. Delay effects in the response of low-grade gliomas to radiotherapy: A mathematical model and its therapeutical implications

    Mathematical Medicine and Biology, Vol. 32, Núm. 3, pp. 307-329

2012

  1. Hypoxic Cell Waves Around Necrotic Cores in Glioblastoma: A Biomathematical Model and Its Therapeutic Implications

    Bulletin of Mathematical Biology, Vol. 74, Núm. 12, pp. 2875-2896

2011

  1. Bright solitary waves in malignant gliomas

    Physical Review E - Statistical, Nonlinear, and Soft Matter Physics, Vol. 84, Núm. 2

  2. Un modelo matemático para tumores cerebrales

    XXII CEDYA Congreso de Ecuaciones Diferenciales y Aplicaciones: XII CMA Congreso de Matemática Aplicada : Palma de Mallorca, 5-9 septiembre de 2011: programa y resúmenes